Literature DB >> 33560186

Breast Cancer Mortality Rates Have Stopped Declining in U.S. Women Younger than 40 Years.

R Edward Hendrick1, Mark A Helvie1, Debra L Monticciolo1.   

Abstract

Background National Center for Health Statistics (NCHS) data for U.S. women have shown a steady decline in breast cancer mortality rates since 1989. Purpose To analyze U.S. breast cancer mortality rates by age decade in women aged 20-79 years and in women aged 20-39 years and women aged 40-69 years. Materials and Methods The authors conducted a retrospective analysis of (a) female breast cancer mortality rates from NCHS data for 1969-2017 for all races and by race and (b) age- and delay-adjusted invasive breast cancer incidence rates from the Surveillance, Epidemiology, and End Results program. Joinpoint analysis was used to determine trends in breast cancer mortality, invasive breast cancer incidence, and distant-stage (metastatic) breast cancer incidence rates. Results Between 1989 and 2010, breast cancer mortality rates decreased by 1.5%-3.4% per year for each age decade from 20 to 79 years (P < .001 for each). After 2010, breast cancer mortality rates continued to decline by 1.2%-2.2% per year in women in each age decade from 40 to 79 years (P < .001 for each) but stopped declining in women younger than 40 years. After 2010, breast cancer mortality rates demonstrated nonsignificant increases of 2.8% per year in women aged 20-29 years (P = .11) and 0.3% per year in women aged 30-39 years (P = .70), results attributable primarily to changes in mortality rates in White women. A contributing factor is that distant-stage breast cancer incidence rates increased by more than 4% per year after the year 2000 in women aged 20-39 years. Conclusion Female breast cancer mortality rates have stopped declining in women younger than 40 years, ending a trend that existed from 1987 to 2010. Conversely, mortality rates have continued to decline in women aged 40-79 years. Rapidly rising distant-stage breast cancer rates have likely contributed to ending the decline in mortality rates in women younger than 40 years. © RSNA, 2021 Online supplemental material is available for this article.

Entities:  

Year:  2021        PMID: 33560186     DOI: 10.1148/radiol.2021203476

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

Review 1.  The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer.

Authors:  Bruce A Bunnell; Elizabeth C Martin; Margarite D Matossian; Courtney K Brock; Khoa Nguyen; Bridgette Collins-Burow; Matthew E Burow
Journal:  Cancer Metastasis Rev       Date:  2022-08-24       Impact factor: 9.237

2.  Delineation of Pathogenomic Insights of Breast Cancer in Young Women.

Authors:  Aswathy Mary Paul; Bijesh George; Sunil Saini; Madhavan Radhakrishna Pillai; Masakazu Toi; Luis Costa; Rakesh Kumar
Journal:  Cells       Date:  2022-06-15       Impact factor: 7.666

3.  Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells.

Authors:  Domenica Scordamaglia; Francesca Cirillo; Marianna Talia; Maria Francesca Santolla; Damiano Cosimo Rigiracciolo; Lucia Muglia; Azzurra Zicarelli; Salvatore De Rosis; Francesca Giordano; Anna Maria Miglietta; Ernestina Marianna De Francesco; Veronica Vella; Antonino Belfiore; Rosamaria Lappano; Marcello Maggiolini
Journal:  J Transl Med       Date:  2022-06-07       Impact factor: 8.440

4.  Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer.

Authors:  Nanda Kumar Yellapu; Thuc Ly; Mihaela E Sardiu; Dong Pei; Danny R Welch; Jeffery A Thompson; Devin C Koestler
Journal:  BMC Cancer       Date:  2022-06-08       Impact factor: 4.638

5.  Embedding the Community and Individuals in Disease Prevention.

Authors:  Martine M Bellanger; Ke Zhou; Sophie A Lelièvre
Journal:  Front Med (Lausanne)       Date:  2022-04-04

6.  Non-SMC condensin I complex subunit H promotes the malignant progression and cisplatin resistance of breast cancer MCF-7 cells.

Authors:  Linhong Liao; Hui Cheng; Shusong Liu
Journal:  Oncol Lett       Date:  2022-07-19       Impact factor: 3.111

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.